Lower Esophageal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Lower Esophageal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 3]
Amgen's Phase 3 trial evaluating rilotumumab for MET-positive gastric/GEJ adenocarcinoma was terminated, indicating the study did not procee…